Coronavirus treatment may come from an unexpected place
Possible therapy may be available for coronavirus, CEO says
After the World Health Organization chief said a coronavirus vaccine could be ready in 18 months, AIM ImmunoTech Inc. CEO Thomas Equels says Ampligen might be helpful in the meantime.
With the World Health Organization recently announcing a vaccine for the deadly coronavirus may be as much as 18 months away, one company is trying to fight the epidemic using an already established medication.
Continue Reading Below
Ampligen, which was used before to treat SARS in animals, is one place AIM ImmunoTech is looking to hopefully alleviate the fatal virus. AIM, an immuno-pharmacy company that develops and researches possible treatments for immune disorders, diseases and cancers, just filed three patent applications to try to get Ampligen targeted to the coronavirus.
"There's no guarantee, but the Wuhan coronavirus is extremely similar in all of the major areas related to the pathogenic response that would indicate that a therapy might be useful because SARS and Wuhan coronavirus are so similar," AIM ImmunoTech Inc. CEO Thomas Equels said on "The Claman Countdown" on Wednesday.
CORONAVIRUS HAS MANY US FIRMS WAITING FOR PRODUCTS TO SHIP
After the deadly SARS outbreak in 2002, the U.S. National Institutes of Health conducted studies on animals using Ampligen to see if it helped, and it did. In fact, Ampligen received a 100 perfect survival rate when animals received human dosages.